Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Melissa B, Epperly currently holds 16,474 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Melissa B, Epperly has been a net seller of ZNTL stock. They have purchased $859.8K and sold $5.2M worth of shares.
Melissa B, Epperly's most recent insider trade was on Apr 17, 2026, when they sold 670 shares at $0.00 per share.
Melissa B, Epperly serves as Executive at Zentalis Pharmaceuticals, Inc. (ZNTL). They have executed 79 insider transactions totaling $6.1M over their tenure at the company.
Melissa B, Epperly holds the position of Executive at Zentalis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Melissa B, Epperly has shown a selling trading pattern, with $859.8K in total purchases and $5.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Melissa B, Epperly was on Mar 16, 2026, when they sold $1.2M worth of ROIV shares. This transaction involved 41,861 shares at $28.68 per share.
Melissa B, Epperly currently owns 16,474 shares of Zentalis Pharmaceuticals, Inc. (ZNTL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Melissa B, Epperly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Melissa B, Epperly has 79 Form 4 filings on record as an insider at Zentalis Pharmaceuticals, Inc..
Set alerts for Melissa B, Epperly and 40,000+ other insiders.